Patients impacted by the Stryker hip recall need to discuss these issues with their doctor. Clinical screening is a key component in determining whether or not their hip components are functioning properly.
New York, New York (PRWEB) January 11, 2013
Bernstein Liebhard LLP is urging all Stryker hip recall patients to undergo blood and imaging tests even if they are not experiencing pain, swelling or other symptoms of a failing hip implant. According to a report from Reuters, Stryker is recommending clinical follow-up for all patients impacted by the July 2012 recall of Rejuvenate and ABG II modular hip stems. The company says it has received reports of patients with no or mild symptoms who still had high levels of metal ions in their bloodstream and evidence of local tissue reactions.*
“Patients impacted by the Stryker hip recall need to discuss these issues with their doctor. Clinical screening is a key component in determining whether or not their hip components are functioning properly,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is currently offering free legal evaluations to individuals affected by the Stryker Rejuvenate recall.
Stryker Rejuvenate Lawsuits
Stryker recalled its Rejuvenate and ABG II modular neck-stems on July 6, 2012, due to a potential for fretting and corrosion at the modular-neck junction that may result in pain, swelling and adverse local tissue reactions. According to Reuters, Stryker disclosed this week that the Stryker hip recall could cost the company as much as $390 million. The ultimate cost could vary, depending on, among other things, the number of Stryker Rejuvenate lawsuits filed against the company. In October, plaintiffs in Stryker hip lawsuits petitioned the New Jersey Supreme Court to consolidate all claims pending in the state in a Multicounty Litigation in Bergen County Superior Court. According to the plaintiffs’ application, 10 lawsuits were pending in New Jersey at that time. **
Stryker also recently posted information on its website stating it had retained Broadspire Services, Inc., a third-party claims administrator, to work directly with patients to manage medical claims and address out-of-pocket costs relating to the Stryker hip recall.*** Bernstein Liebhard LLP is advising patients that they should consider speaking with an attorney before they begin the Broadspire Stryker claims process, as any information they disclose to a Broadspire representative or in the course of the claims process could be used as evidence in their Stryker hip lawsuit.
Individuals who have suffered hip implant failures, metal poisoning, pain, or revision surgery allegedly due to the recalled Rejuvenate and ABG II components may be entitled to file a Stryker hip recall lawsuit seeking compensation for their medical care, pain and suffering, and other damages. A wealth of information regarding the Stryker Rejuvenate recall is available at Bernstein Liebhard LLP’s Stryker hip recall website. Free lawsuit evaluations can be obtained by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP